How it works

From source to protocol, in five steps.

  1. 01

    Source

    Peptide ingredient is made at a vetted, new-build GMP facility. Our team inspected it in person before we signed.

  2. 02

    Test

    Samples and batches are tested by independent laboratories for identity and purity before anything moves on.

  3. 03

    Finish in-market

    At our own licensed sites, product is sterile-filled, freeze-dried and labelled in the market where it will be sold.

  4. 04

    Release

    A licensed pharmacist or Qualified Person releases each batch, and its certificate of analysis is published.

  5. 05

    Guide

    Through the members club, a medical professional helps each member build and follow a supervised protocol.

Lab verification

What every certificate of analysis shows.

Each batch carries a public certificate, linked from the product and from the vial’s batch number. Until our own QC labs are licensed, every batch is tested by an independent laboratory.

Packaging with a certificate of analysis
Identity
Confirms the compound is what the label says, by mass spectrometry.
Purity
Percentage purity by HPLC, with impurity profile.
Sterility
Absence of microbial contamination in the finished vial.
Endotoxins
Bacterial endotoxin level against the product limit.
Batch & dates
Batch number, manufacture and expiry dates, releasing site.
Laboratory
The independent lab that performed the tests.
Science & safety

Built for a category regulators are defining right now.

  1. Apr 2026

    FDA

    Removes 12 peptides from its restricted Category 2 list.

  2. Jun 2026

    EMA

    First EU-wide quality guideline for synthetic peptides takes effect.

  3. Jul 2026

    FDA advisory committee

    Votes to recommend three peptides for compounding.

  4. Oct 2026

    SAHPRA

    Publishes South Africa’s first synthetic-peptide guideline.

Evidence before claims

We describe what the research shows, cite it, and say where evidence is thin.

Supervised where required

Products that need a prescriber or pharmacist are only offered through one.

Report and act

Adverse-event reporting is built into every platform, and batches can be traced and recalled.

Waitlist · Launching 2027

Be first to know.

Launch updates by market, and early access to the members club and protocol builder.

I am

Launch updates only. Unsubscribe any time. See our privacy notice.